ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

NIH Updates Policy On Large Grants

May 10, 1996

Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million

March 5, 1999

In Brief: Owens Gives Up Hopkins Hospital Presidency, Resume Full Time Role As Center Director

July 15, 1988

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments

March 22, 1985

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009